共 50 条
- [1] Re: A Prospective Randomised Placebo-controlled Study of the Impact of Dutasteride/Tamsulosin Combination Therapy on Sexual Function Domains in Sexually Active Men with Lower Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) [J]. EUROPEAN UROLOGY, 2019, 75 (02) : 344 - 345
- [2] A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) [J]. BJU INTERNATIONAL, 2018, 121 (04) : 647 - 658
- [3] Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo-controlled study [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2019, 73 (09) : 1 - 9
- [6] Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo-controlled study [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2020, 74 (05)
- [7] THE EFFECTS OF DUTASTERIDE OR TAMSULOSIN ALONE AND IN COMBINATION ON STORAGE AND VOIDING SYMPTOMS IN MEN WITH LOWER URINARY TRACT SYMPTOMS (LUTS) AND BENIGN PROSTATIC HYPERPLASIA (BPH): 4-YEAR DATA FROM THE COMBINATION OF AVODART AND TAMSULOSIN (CombAT) STUDY [J]. BJU INTERNATIONAL, 2011, 107 (09) : 1431 - 1431
- [8] Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract (LUTS) and benign prostatic hyperplasia (BPH) [J]. JOURNAL OF UROLOGY, 2004, 171 (04): : 357 - 357
- [9] Urodynamic effects of the combination of tamsulosin and daily tadalafil in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: a randomized, placebo-controlled clinical trial [J]. International Urology and Nephrology, 2013, 45 : 39 - 43